Kedrion SpA’s Shareholders approve 2014 financial statement
A 466 million euros’ turnover with a 9,8% rise on 2013
Kedrion supported the XI World Hemophilia Day
An increasingly tailor-made prophylaxis lets sports and hemorrhagic conditions live together
I triumphed in my race for life!
I was about six months old when I was diagnosed with severe hemophilia A.At the time, each hemorrhage required hospitalization. Sadly, by the time I was treated, the affected joints had been invaded by blood and were unbearably painful. It was a difficult childhood, but I did not give up, and from my adolescence on
Kedrion unveils its new manufacturing plant in Castelvecchio Pascoli
The company has invested over 67 million euros and is expected to create between 70 and 90 new jobs
Kedrion CEO took part in “Italy meets the USA” summit on February 10, 2015
The NY meeting was aimed at highlighting significant investment opportunities in Italy
SIPPET Study: interim analysis confirms the original hypothesis
The Study on inhibitors in Hemophilia A is safe to continue after Investigators’ Meeting in San Francisco (Dec 2014)
Fighting diseases of the new-born: Kedrion attended UENPS conference
The company also supported a mini-marathon to eradicate HDFN
A life spent donating plasma
“Donating is part of my life,” observes Heinz Kühlein. And he means it: Heinz has been donating blood or blood plasma since 1970, when he was doing his army service. Ten years later he was donating at the Bavarian Red Cross in Bayreuth and that is where he meet Angela Beck, who was working there.
Kedrion receives the “VedoGreen, Green Excellence in Innovation” Award
The awards ceremony held in Milan on November 17, during Waiting for Expo 2015, Green Economy 2.0
Kedrion joins the programme “ELITE for Large Corporates”
Launched by Borsa Italiana, ELITE is targeted to companies aiming at strengthening their global leadership